跳转至

◀返回

新奇感增强

新奇感增强被定义为一种对外部环境的特定部分或整体产生的着迷感增加[1]、敬畏感[1][2][3]以及欣赏感[3][4]的体验。这可能导致一种常常令人不知所措的印象，即自然的、存在的、日常的事件，甚至是家居用品等平凡概念，现在都变得相当深刻、有趣且充满意义了呢[5][6]。

这种效应的体验通常会迫使经历者以一种细节程度和强度去承认、思考和欣赏周围的事物，这种程度在每天的清醒状态下是很难达到的哦。通常会用“惊奇感”[1][3]或“焕然一新的世界”[4]这样的短语来描述它。

新奇感增强通常伴随着其他同时发生的效应，如个人偏见抑制、情绪强化和灵性增强，从而进一步强化体验。它最常见于在中等剂量的迷幻剂类化合物的影响下诱发，例如LSD、赛洛西宾和麦斯卡林。然而，在大麻类、解离剂和共情剂的影响下，也可能在较小程度上发生呢。

内容

体验报告

在我们的主观效应索引中，描述此效应的轶事报告包括：

  • 报告/psychounautwiki/Experience:22mg_2C-B(oral)/_100ug_1P-LSD(sublingual)-_My_first_time_tripping_alone(2_days_in_a_row)/_100ug_1P-LSD(sublingual)-_My_first_time_tripping_alone(2_days_in_a_row))
  • 报告/psychounautwiki/Experience:36mg_4-AcO-DiPT-_Truly,_one_for_the_psychedelic_animals_among_us
  • 报告/psychounautwiki/Experience:5-EAPB(60mg)%2B_2-FMA(20mg)%2B_4-AcO-DMT(10mg)-_Emotional_catharsis%2B_2-FMA_(20mg)%2B_4-AcO-DMT(10mg)_-_Emotional_catharsis)
  • 报告/psychounautwiki/Experience:12_mg_AMT_-_Nicely_Surprised
  • 报告/psychounautwiki/Experience:150mg_MDMA_%2B_20mg_2C-B_-_I_designed_it_this_way_myself
  • 报告/psychounautwiki/Experience:2_tabs_DOB_-_My_DOB_Nightmare
  • 报告/psychounautwiki/Experience:2.5g_-_Swim%27s_first_mushroom_trip
  • 报告/psychounautwiki/Experience:225ug_-_Sheer_Awe_and_Joy
  • 报告/psychounautwiki/Experience:250mg_MDA_/250mg_MDMA-_unnecessarily_large_dosage
  • 报告/psychounautwiki/Experience:25mg_-_A_labyrinth_of_organs_and_a_storybook_walk
  • 报告/psychounautwiki/Experience:25mg_3-MeO-PCP_-_Enhanced_film_experience
  • 报告/psychounautwiki/Experience:25mg_Deschloroketamine_-_My_first_time_orally_dosing_DCK
  • 报告/psychounautwiki/Experience:3_Grams_of_Mushrooms_-_Reset_on_my_Life,_Experiencing_Satori_and_the_Cosmic_Perspective
  • 报告/psychounautwiki/Experience:3.5g_psilocybe_cubensis_-_Relinquishing_of_Material_Chains/Fear_and_Desolation
  • 报告/psychounautwiki/Experience:300ug_LSD_-_Profound_religious_experience
  • 报告/psychounautwiki/Experience:300%C2%B5g_LSD_-_Togetherness_and_the_Silent_Dusk
  • 报告/psychounautwiki/Experience:337mg_DMT_fumarate_-_A_Day_With_DMT
  • 报告/psychounautwiki/Experience:4.5g_-_The_Grand_Introduction_to_Beauty_and_Fear
  • 报告/psychounautwiki/Experience:40mg_-_Brothermind_and_the_Forest%27s_Hand
  • 报告/psychounautwiki/Experience:4x_200ug_tabs_-_You_do_not_need_to_understand
  • 报告/psychounautwiki/Experience:6g_mimosa_/2.5_g_syrian_rue-_Best_cake_I%27ve_had_for_a_while
  • 报告/psychounautwiki/Experience:70mg_Lisdexamfetamine_(oral)-_My_first_stimulant_experience-_My_first_stimulant_experience)
  • 报告/psychounautwiki/Experience:750mg_-_Experiencing_Void;_Dissociation_Of_Reality_And_Self
  • 报告/psychounautwiki/Experience:800ug_LSD_-_3D_Vision
  • 报告/psychounautwiki/Experience:DMT_(~50mg)%2B_Cannabis-Geometric_Angels%2B_Cannabis_-_Geometric_Angels)
  • 报告/psychounautwiki/Experience:LSD_(150%C2%B5g)%2B_Cannabis-150%C2%B5g_lsd_and_a_shitload_of_weed%2B_Cannabis_-_150%C2%B5g_lsd_and_a_shitload_of_weed)
  • 报告/psychounautwiki/Experience:LSD_(400ug,Oral)-An_afternoon_in%22a%22_garden_-An_afternoon_in%22a%22_garden)
  • 报告/psychounautwiki/Experience:LSD_(~500%CE%BCg,sublingual)%2B_Noopept_-Mind_Reset%2B_Noopept_-_Mind_Reset)
  • 报告/psychounautwiki/Experience:Mushrooms_(~0.5_g)-_Autonomous_Voice-_Autonomous_Voice)
  • 报告/psychounautwiki/Experience:Mushrooms_and_Snuff_Films_--Trip_Report(3.5_grams))
  • 报告/psychounautwiki/Experience:Nutmeg_(8_teaspoons)-_My_Mom_Introduces_Me_To_Genesis_and_Other_Things-_My_Mom_Introduces_Me_To_Genesis_and_Other_Things)
  • 报告/psychounautwiki/Experience:Psilocybin_Mushroom_(0.16_g,Oral)-Dosage_Independent_Intensity-_Dosage_Independent_Intensity)

另见

参考文献

  1. ↑ 1.0 1.1 1.2 Hunt, Harry T. (1976). "A Test of the Psychedelic Model of Altered States of Consciousness". Archives of General Psychiatry. 33 (7): 867. doi:10.1001/archpsyc.1976.01770070097012. ISSN 0003-990X.
  2. ↑ Bonner, Edward T.; Friedman, Harris L. (2011). "A conceptual clarification of the experience of awe: An interpretative phenomenological analysis". The Humanistic Psychologist. 39 (3): 222–235. doi:10.1080/08873267.2011.593372. ISSN 1547-3333.
  3. ↑ 3.0 3.1 3.2 Griffiths, Roland R; Johnson, Matthew W; Richards, William A; Richards, Brian D; Jesse, Robert; MacLean, Katherine A; Barrett, Frederick S; Cosimano, Mary P; Klinedinst, Maggie A (2017). "Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors". Journal of Psychopharmacology. 32 (1): 49–69. doi:10.1177/0269881117731279. ISSN 0269-8811.
  4. ↑ 4.0 4.1 Das, Saibal; Barnwal, Preeti; Ramasamy, Anand; Sen, Sumalya; Mondal, Somnath (2016). "Lysergic acid diethylamide: a drug of 'use'?". Therapeutic Advances in Psychopharmacology. 6 (3): 214–228. doi:10.1177/2045125316640440. ISSN 2045-1253.
  5. ↑ Bowers, Malcolm B. (1966). ""Psychedelic" Experiences in Acute Psychoses". Archives of General Psychiatry. 15 (3): 240. doi:10.1001/archpsyc.1966.01730150016003. ISSN 0003-990X.
  6. ↑ Belser, Alexander B.; Agin-Liebes, Gabrielle; Swift, T. Cody; Terrana, Sara; Devenot, Neşe; Friedman, Harris L.; Guss, Jeffrey; Bossis, Anthony; Ross, Stephen (2017). "Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis". Journal of Humanistic Psychology. 57 (4): 354–388. doi:10.1177/0022167817706884. ISSN 0022-1678.